BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2317160)

  • 1. Fate of fibrinogen in human arterial intima.
    Smith EB; Keen GA; Grant A; Stirk C
    Arteriosclerosis; 1990; 10(2):263-75. PubMed ID: 2317160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interactions in human atherosclerotic plaques.
    Smith EB
    Am J Pathol; 1977 Mar; 86(3):665-74. PubMed ID: 65917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
    Smith EB
    Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostatic factors in human aortic intima.
    Smith EB; Staples EM
    Lancet; 1981 May; 1(8231):1171-4. PubMed ID: 6112525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?
    Smith EB; Crosbie L
    Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.
    Bini A; Fenoglio J; Sobel J; Owen J; Fejgl M; Kaplan KL
    Blood; 1987 Apr; 69(4):1038-45. PubMed ID: 2950941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelium in sequestration of lipoprotein and firbrinogen in aortic lesions, thrombi, and graft pseudo-intimas.
    Smith EB; Staples EM; Dietz HS; Smith RH
    Lancet; 1979 Oct; 2(8147):812-6. PubMed ID: 90916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apo B, fibrinogen-fibrin and fibronectin in the intima of the normal human aorta and large arteries and in atherosclerosis].
    Shekhonin BV; Tararak EM; Samokhin GP; Vinogradov DV; Kotelianskiĭ VE
    Arkh Patol; 1990; 52(4):16-21. PubMed ID: 2201275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin-related antigens in human aortic intima.
    Smith EB; Crosbie L; Carey S
    Semin Thromb Hemost; 1996; 22(4):347-50. PubMed ID: 8944420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of fibrinogen and fibrin by plasmin and nonplasmin proteases in the chronic subdural hematoma: evaluation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot.
    Nomura S; Kashiwagi S; Ito H; Mimura Y; Nakamura K
    Electrophoresis; 1993 Dec; 14(12):1318-21. PubMed ID: 8137796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. I. Relation between fibrin and immobilization of apo B-containing lipoprotein.
    Smith EB; Keen GA; Grant A
    Atherosclerosis; 1990 Oct; 84(2-3):165-71. PubMed ID: 2149267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen/fibrin in atherogenesis.
    Smith EB; Thompson WD; Crosbie L; Stirk CM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein.
    Smith EB; Alexander KM; Massie IB
    Atherosclerosis; 1976; 23(1):19-39. PubMed ID: 233764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inter-relation of fibrin, lipoprotein(a) and plasminogen in human atherosclerotic lesions.
    Smith EB; Crosbie L; Cochran S
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):495-8. PubMed ID: 2151935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin.
    Smith EB; Massie IB; Alexander KM
    Atherosclerosis; 1976 Oct; 25(1):71-84. PubMed ID: 186079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis.
    Shekhonin BV; Tararak EM; Samokhin GP; Mitkevich OV; Mazurov AV; Vinogradov DV; Vlasik TN; Kalantarov GF; Koteliansky VE
    Atherosclerosis; 1990 Jun; 82(3):213-26. PubMed ID: 2198029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test.
    Bach-Gansmo ET; Godal HC; Skjønsberg OH
    Thromb Res; 1998 Nov; 92(3):125-34. PubMed ID: 9806364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.